Both in Pharmaceuticals
Shattuck Labs vs Monopar Therapeutics
Over the past year STTK returned +178.1% and MNPR returned −3.8%; their daily moves had a correlation of 0.29.
STTK +178.1% MNPR −3.8%Growth of $1, one year, split-adjusted
| Metric | STTK | MNPR |
|---|---|---|
| Price | $5.84 | $74.23 |
| Market cap | $586.1M | $498.2M |
| Today | +8.75% | +3.86% |
| 1 month | −4.4% | −22.5% |
| 6 months | −24.7% | +40.8% |
| Year to date | +60.0% | +13.7% |
| 1 year | +222.7% | −7.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 586.1× | — |
| Net cash | $208.3M | $134.3M |
| Dividend yield | — | — |
| Volatility (60d) | 62.7% | 53.8% |
| Short % of float | 13.9% | 22.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).